Status:
WITHDRAWN
Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses
Lead Sponsor:
Alcon Research
Conditions:
Aphakia
Presbyopia
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
The purpose of this post-market study is to describe the long-term safety and performance of AcrySof IQ Vivity and AcrySof IQ Vivity Toric intraocular lens (IOL) models in a real-world setting through...
Detailed Description
This study includes a retrospective chart review to obtain preoperative, operative, and post-operative data, and one prospective visit to collect key long-term safety and performance endpoints in a sa...
Eligibility Criteria
Inclusion
- Key
- 22 years old or older at Visit 1.
- Able to understand and sign an approved informed consent form.
- Implantation of AcrySof IQ Vivity and/or Vivity Toric IOL models in both eyes for 3 to 5 years prior to enrollment.
- Documented medical history and required pre-operative baseline information available for retrospective data collection.
- Other protocol-specified inclusion criteria may apply.
- Key
Exclusion
- Corneal refractive surgery after AcrySof Vivity or AcrySof Vivity Toric IOL implantation.
- Pregnant or nursing at the time of enrollment.
- Childbirth after IOL implantation.
- Other protocol-specified exclusion criteria may apply.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06541795
Start Date
June 1 2025
End Date
December 1 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134